Castagnoli R et al. (2020). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents A Systematic Review COVID-19 y población pediátrica/adolescente / 27 de Abril del 2020 Read more
GINA 2020 (19/03/2020). Recomendaciones medicación asma inhalada COVID19 COVID-19 y enfermedades respiratorias / 25 de Abril del 2020 Read more
GOLD COVID-19. Recomendaciones EPOC COVID-19 y enfermedades respiratorias / 25 de Abril del 2020 Read more
Vaduganathan M. et al. (2020). Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19 COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Gheblawi M. et al. (2020). Angiotensin Converting Enzyme 2 SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Yin S. et al. (2020). Diference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Tang N. et al. (2020). Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Wenzhog L (2020). COVID-19 Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Amgalan A (2020). Letter to de Editor ExPloring possible mechanisms for COVID-19 induced thrombocytopenia Unanswered Questions COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Tang N et al. (2020). Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more